These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 29232160)

  • 1. MicroRNA-145 Antagonism Reverses TGF-β Inhibition of F508del CFTR Correction in Airway Epithelia.
    Lutful Kabir F; Ambalavanan N; Liu G; Li P; Solomon GM; Lal CV; Mazur M; Halloran B; Szul T; Gerthoffer WT; Rowe SM; Harris WT
    Am J Respir Crit Care Med; 2018 Mar; 197(5):632-643. PubMed ID: 29232160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tgf-beta downregulation of distinct chloride channels in cystic fibrosis-affected epithelia.
    Sun H; Harris WT; Kortyka S; Kotha K; Ostmann AJ; Rezayat A; Sridharan A; Sanders Y; Naren AP; Clancy JP
    PLoS One; 2014; 9(9):e106842. PubMed ID: 25268501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurements of Functional Responses in Human Primary Lung Cells as a Basis for Personalized Therapy for Cystic Fibrosis.
    Awatade NT; Uliyakina I; Farinha CM; Clarke LA; Mendes K; Solé A; Pastor J; Ramos MM; Amaral MD
    EBioMedicine; 2015; 2(2):147-53. PubMed ID: 26137539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming Growth Factor-β1 Selectively Recruits microRNAs to the RNA-Induced Silencing Complex and Degrades CFTR mRNA under Permissive Conditions in Human Bronchial Epithelial Cells.
    Mitash N; Mu F; Donovan JE; Myerburg MM; Ranganathan S; Greene CM; Swiatecka-Urban A
    Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31590401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del).
    Southern KW; Murphy J; Sinha IP; Nevitt SJ
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD010966. PubMed ID: 33331662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-16 rescues F508del-CFTR function in native cystic fibrosis epithelial cells.
    Kumar P; Bhattacharyya S; Peters KW; Glover ML; Sen A; Cox RT; Kundu S; Caohuy H; Frizzell RA; Pollard HB; Biswas R
    Gene Ther; 2015 Nov; 22(11):908-16. PubMed ID: 26133785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correctors (specific therapies for class II CFTR mutations) for cystic fibrosis.
    Southern KW; Patel S; Sinha IP; Nevitt SJ
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD010966. PubMed ID: 30070364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two Small Molecules Restore Stability to a Subpopulation of the Cystic Fibrosis Transmembrane Conductance Regulator with the Predominant Disease-causing Mutation.
    Meng X; Wang Y; Wang X; Wrennall JA; Rimington TL; Li H; Cai Z; Ford RC; Sheppard DN
    J Biol Chem; 2017 Mar; 292(9):3706-3719. PubMed ID: 28087700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CFTR dysfunction increases endoglin and TGF-β signaling in airway epithelia.
    Nicola T; Kabir FL; Coric T; Wall SB; Zhang W; James M; MacEwen M; Ren C; Halloran B; Ambalavanan N; Harris WT
    Physiol Rep; 2019 Feb; 7(4):e13977. PubMed ID: 30806029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Akt-driven TGF-β and DKK1 Secretion Impairs F508del Cystic Fibrosis Airway Epithelium Polarity.
    Idris T; Bachmann M; Bacchetta M; Wehrle-Haller B; Chanson M; Badaoui M
    Am J Respir Cell Mol Biol; 2024 Jul; 71(1):81-94. PubMed ID: 38531016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmentation of Cystic Fibrosis Transmembrane Conductance Regulator Function in Human Bronchial Epithelial Cells via SLC6A14-Dependent Amino Acid Uptake. Implications for Treatment of Cystic Fibrosis.
    Ahmadi S; Wu YS; Li M; Ip W; Lloyd-Kuzik A; Di Paola M; Du K; Xia S; Lew A; Bozoky Z; Forman-Kay J; Bear CE; Gonska T
    Am J Respir Cell Mol Biol; 2019 Dec; 61(6):755-764. PubMed ID: 31189070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del).
    Heneghan M; Southern KW; Murphy J; Sinha IP; Nevitt SJ
    Cochrane Database Syst Rev; 2023 Nov; 11(11):CD010966. PubMed ID: 37983082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ORKAMBI-Mediated Rescue of Mucociliary Clearance in Cystic Fibrosis Primary Respiratory Cultures Is Enhanced by Arginine Uptake, Arginase Inhibition, and Promotion of Nitric Oxide Signaling to the Cystic Fibrosis Transmembrane Conductance Regulator Channel.
    Wu YS; Jiang J; Ahmadi S; Lew A; Laselva O; Xia S; Bartlett C; Ip W; Wellhauser L; Ouyang H; Gonska T; Moraes TJ; Bear CE
    Mol Pharmacol; 2019 Oct; 96(4):515-525. PubMed ID: 31427400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CFTR Amplifier Nesolicaftor Rescues TGF-β1 Inhibition of Modulator-Corrected F508del CFTR Function.
    Bengtson C; Silswal N; Baumlin N; Yoshida M; Dennis J; Yerrathota S; Kim M; Salathe M
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unravelling the Regions of Mutant F508del-CFTR More Susceptible to the Action of Four Cystic Fibrosis Correctors.
    Amico G; Brandas C; Moran O; Baroni D
    Int J Mol Sci; 2019 Nov; 20(21):. PubMed ID: 31683989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of cystic fibrosis transmembrane conductance regulator by microRNA-145, -223, and -494 is altered in ΔF508 cystic fibrosis airway epithelium.
    Oglesby IK; Chotirmall SH; McElvaney NG; Greene CM
    J Immunol; 2013 Apr; 190(7):3354-62. PubMed ID: 23436935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-transcriptional regulation of cystic fibrosis transmembrane conductance regulator expression and function by microRNAs.
    Ramachandran S; Karp PH; Osterhaus SR; Jiang P; Wohlford-Lenane C; Lennox KA; Jacobi AM; Praekh K; Rose SD; Behlke MA; Xing Y; Welsh MJ; McCray PB
    Am J Respir Cell Mol Biol; 2013 Oct; 49(4):544-51. PubMed ID: 23646886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In utero and postnatal ivacaftor/lumacaftor therapy rescues multiorgan disease in CFTR-F508del ferrets.
    Evans IA; Sun X; Liang B; Vegter AR; Guo L; Lynch TJ; Zhang Y; Zhang Y; Yi Y; Yang Y; Feng Z; Park SY; Shonka A; McCumber H; Qi L; Wu P; Liu G; Lacina A; Wang K; Gibson-Corley KN; Meyerholz DK; Limoli DH; Rosen BH; Yan Z; Bartels DJ; Engelhardt JF
    JCI Insight; 2024 Apr; 9(8):. PubMed ID: 38646935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Neutralizing Aptamer to TGFBR2 and miR-145 Antagonism Rescue Cigarette Smoke- and TGF-β-Mediated CFTR Expression.
    Dutta RK; Chinnapaiyan S; Rasmussen L; Raju SV; Unwalla HJ
    Mol Ther; 2019 Feb; 27(2):442-455. PubMed ID: 30595527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular phosphate enhances the function of F508del-CFTR rescued by CFTR correctors.
    Saint-Criq V; Wang Y; Delpiano L; Lin J; Sheppard DN; Gray MA
    J Cyst Fibros; 2021 Sep; 20(5):843-850. PubMed ID: 34020896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.